Efficacy and safety of hematopoietic stem cell (HSC) remobilization with plerixafor plus G-CSF in patients with non-hematologic malignancies

被引:0
|
作者
Horwitz, M.
Schriber, J.
Libby, E. N.
Gorak, E. J.
Mody, P.
Marulkar, S.
Holman, P. R.
机构
[1] Duke Univ, Med Ctr, Durham, NC USA
[2] Banner Blood & Marrow Transplant Program, Phoenix, AZ USA
[3] Univ New Mexico, Ctr Canc, Albuquerque, NM 87131 USA
[4] Geisinger Med Ctr, Danville, PA 17822 USA
[5] Genzyme Corp, Cambridge, MA USA
[6] Univ Calif San Diego, La Jolla, CA 92093 USA
关键词
D O I
10.1200/jco.2010.28.15_suppl.e15072
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e15072
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Comparing Cyclophosphamide with G-CSF and Plerixafor with G-CSF As Stem Cell Mobilization (SCM) Regimens for Multiple Myeloma (MM) Patients: An Evaluation of Mobilization Efficacy and Toxicity
    Tan, Carlyn Rose C.
    Pancari, Philip A.
    Ulicny, John
    Martin, Mary Ellen
    Barta, Stefan Klaus
    Kropf, Patricia Lamont
    Fung, Henry C.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S136 - S136
  • [42] Safety and efficacy of upfront plerixafor plus G-CSF versus placebo plus G-CSF for mobilization of CD34+ hematopoietic progenitor cells in patients ≥60 and <60 years of age with non-Hodgkin's lymphoma or multiple myeloma
    Micallef, Ivana N.
    Stiff, Patrick J.
    Stadtmauer, Edward A.
    Bolwell, Brian J.
    Nademanee, Auayporn P.
    Maziarz, Richard T.
    Partisano, Angela M.
    Marulkar, Sachin
    DiPersio, John F.
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (12) : 1017 - 1023
  • [43] ENDOSTEAL MACROPHAGES MAINTAIN THE HEMATOPOIETIC STEM CELL (HSC) NICHE AND PARTICIPATE IN HSC MOBILIZATION INDUCED BY G-CSF OR CHEMOTHERAPY
    Levesque, J. P.
    Raggatt, L. J.
    Pettit, A. R.
    Sims, N. A.
    Bendall, L. J.
    Helwani, F.
    Winkler, I. G.
    EXPERIMENTAL HEMATOLOGY, 2009, 37 (09) : S31 - S31
  • [44] A clinical comparison of the efficacy and safety of biosimilar G-CSF and originator G-CSF in haematopoietic stem cell mobilization
    Manko, Joanna
    Walter-Croneck, Adam
    Jawniak, Dariusz
    Grzasko, Norbert
    Gorska-Kosicka, Magdalena
    Cioch, Maria
    Dmoszynska, Anna
    PHARMACOLOGICAL REPORTS, 2014, 66 (02) : 239 - 242
  • [45] A clinical comparison of the efficacy and safety of biosimilar G-CSF and originator G-CSF in haematopoietic stem cell mobilization
    Joanna Manko
    Adam Walter-Croneck
    Dariusz Jawniak
    Norbert Grzasko
    Magdalena Gorska-Kosicka
    Maria Cioch
    Anna Dmoszynska
    Pharmacological Reports, 2014, 66 : 239 - 242
  • [46] REVERSAL OF HEPATIC FIBROSIS IN AN INDUCED MODEL OF CHRONIC LIVER INJURY BY G-CSF-, PLERIXAFOR- OR G-CSF plus PLERIXAFOR-MOBILIZATION OF HEMATOPOIETIC STEM CELLS
    Tsolaki, E.
    Gounari, E.
    Zogas, N.
    Athanasiou, E.
    Siotou, E.
    Yiangou, M.
    Anagnostopoulos, A.
    Yannaki, E.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S132 - S132
  • [47] Plerixafor and G-CSF for autologous stem cell mobilization in AL amyloidosis
    E Kaul
    G Shah
    C Chaulagain
    R L Comenzo
    Bone Marrow Transplantation, 2014, 49 : 1233 - 1233
  • [48] Characterization of peripheral blood stem cell grafts mobilized by G-CSF and plerixafor in comparison to G-CSF alone
    Gaugler, B.
    Arbez, J.
    Frikeche, J.
    Le Gouill, S.
    Gastinne, T.
    Blin, N.
    Chevallier, P.
    Guillaume, T.
    Delaunay, J.
    Ayari, S.
    Rialland, F.
    Mahe, B.
    Dubruille, V.
    Clavert, A.
    Rolland, V.
    Saas, P.
    Moreau, P.
    Derenne, S.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S61 - S62
  • [49] Plerixafor and G-CSF for autologous stem cell mobilization in AL amyloidosis
    Kaul, E.
    Shah, G.
    Chaulagain, C.
    Comenzo, R. L.
    BONE MARROW TRANSPLANTATION, 2014, 49 (09) : 1233 - 1233
  • [50] Diabetes Limits Stem Cell Mobilization Following G-CSF but Not Plerixafor
    Fadini, Gian Paolo
    Fiala, Mark
    Cappellari, Roberta
    Danna, Marianna
    Park, Soo
    Poncina, Nicol
    Menegazzo, Lisa
    Albiero, Mattia
    DiPersio, John
    Stockerl-Goldstein, Keith
    Avogaro, Angelo
    DIABETES, 2015, 64 (08) : 2969 - 2977